PRESTIGE CONSUMER HEALTHCARE INC. Exchange Rate Effect on Cash
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) reported Exchange Rate Effect on Cash of -$19.00 thousand for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-01.
Discontinued › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents · last filed 2019-08-01
- PRESTIGE CONSUMER HEALTHCARE INC. effect of exchange rate on cash and cash equivalents for the quarter ending 2019-06-30 was -$19.00K.
- PRESTIGE CONSUMER HEALTHCARE INC. effect of exchange rate on cash and cash equivalents for the quarter ending 2018-06-30 was -$283.00K, a 183.98% decline year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. effect of exchange rate on cash and cash equivalents for the quarter ending 2017-06-30 was $337.00K.
- PRESTIGE CONSUMER HEALTHCARE INC. effect of exchange rate on cash and cash equivalents for the quarter ending 2016-06-30 was -$760.00K, a 1026.83% decline year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. effect of exchange rate on cash and cash equivalents for fiscal 2018 was $1.10M.
- PRESTIGE CONSUMER HEALTHCARE INC. effect of exchange rate on cash and cash equivalents for fiscal 2017 was -$409.00K, a 182.29% decline from fiscal 2016.
- PRESTIGE CONSUMER HEALTHCARE INC. effect of exchange rate on cash and cash equivalents for fiscal 2016 was $497.00K.
- PRESTIGE CONSUMER HEALTHCARE INC. effect of exchange rate on cash and cash equivalents for fiscal 2015 was -$1.27M, a 712.98% decline from fiscal 2014.
| Period end | Effect of Exchange Rate on Cash and Cash Equivalents 3 month | Effect of Exchange Rate on Cash and Cash Equivalents 6 month | Effect of Exchange Rate on Cash and Cash Equivalents 9 month | Effect of Exchange Rate on Cash and Cash Equivalents 12 month |
|---|---|---|---|---|
| 2019-06-30 | -$19.00K 10-Q · filed 2019-08-01 | |||
| 2018-12-31 | -$758.00K 10-Q · filed 2019-02-07 | |||
| 2018-09-30 | -$352.00K 10-Q · filed 2018-11-01 | |||
| 2018-06-30 | -$283.00K 10-Q · filed 2019-08-01 | |||
| 2018-03-31 | $1.10M 10-K · filed 2018-05-10 | |||
| 2017-12-31 | $1.14M 10-Q · filed 2019-02-07 | |||
| 2017-09-30 | $1.01M 10-Q · filed 2018-11-01 | |||
| 2017-06-30 | $337.00K 10-Q · filed 2018-08-02 | |||
| 2017-03-31 | -$409.00K 10-K · filed 2018-05-10 | |||
| 2016-12-31 | -$1.88M 10-Q · filed 2018-02-01 | |||
| 2016-09-30 | -$397.00K 10-Q · filed 2017-11-02 | |||
| 2016-06-30 | -$760.00K 10-Q · filed 2017-08-03 | |||
| 2016-03-31 | $497.00K 10-K · filed 2018-05-10 | |||
| 2015-12-31 | -$333.00K 10-Q · filed 2017-02-02 | |||
| 2015-09-30 | -$811.00K 10-Q · filed 2016-11-03 | |||
| 2015-06-30 | $82.00K 10-Q · filed 2016-08-04 | |||
| 2015-03-31 | -$1.27M 10-K · filed 2017-05-17 | |||
| 2014-12-31 | -$746.00K 10-Q · filed 2016-02-04 | |||
| 2014-09-30 | -$316.00K 10-Q · filed 2015-11-05 | |||
| 2014-06-30 | $104.00K 10-Q · filed 2015-08-06 | |||
| 2014-03-31 | $208.00K 10-K · filed 2016-05-17 | |||
| 2013-12-31 | $151.00K 10-Q · filed 2015-02-05 | |||
| 2013-09-30 | $156.00K 10-Q · filed 2014-11-06 | |||
| 2013-06-30 | -$3.00K 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | -$54.00K 10-K · filed 2015-05-14 | |||
| 2012-12-31 | $13.00K 10-Q · filed 2014-02-07 | |||
| 2012-09-30 | $14.00K 10-Q · filed 2013-11-07 | |||
| 2012-06-30 | -$24.00K 10-Q · filed 2013-08-01 | |||
| 2012-03-31 | $1.00K 10-K · filed 2014-05-19 | |||
| 2011-12-31 | -$31.00K 10-Q · filed 2013-02-07 | |||
| 2011-09-30 | -$32.00K 10-Q · filed 2012-11-07 | |||
| 2011-06-30 | -$2.00K 10-Q · filed 2012-08-09 | |||
| 2011-03-31 | $0.00 10-K · filed 2013-05-17 | |||
| 2010-12-31 | $0.00 10-Q · filed 2012-02-09 | |||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-09 | |||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-05 | |||
| 2010-03-31 | $0.00 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |